|
Twitter
|
Facebook
|
Google+
|
VKontakte
|
LinkedIn
|
Viadeo
|
English
|
Français
|
Español
|
العربية
|
المجلة الدولية للإبداع والدراسات التطبيقية
ZDB-ID: 2703985-7     OCLC: 828807274     CODEN: IJIABO     ISSN: 2028-9324
السبت 15 يونيو/ حزيران 2024
 
 
  لا يمكنكم حاليا إرسال البحوث قصد النشر  
 
 
 

Jalila El Bakkouri


Personal

Name Jalila El Bakkouri
Affiliation Laboratoire d’Immunologie, CHU Ibn Rochd, Faculté de Médecine et de Pharmacie, Université Hassan II, Casablanca, Morocco

Documents: 4

Document title Date Issue
Biological profile of food allergies in children
[ Profil biologique des allergies alimentaires chez les enfants ]

Author(s): Rachid Elfaiz, Fassih Mohamed, Hsai Fatima Ezzahra, Saoutal Hajar, Asmaa Drissi Bourhanbour, and Jalila El Bakkouri
Show abstract   Full Text
2023 39 (3) , pp. 1149-1154
Correlation of Western Blot profile with clinical and immunological stages in HIV-infected patients in Morocco
[ Corrélation du profil Western Blot avec les stades cliniques et immunologiques chez les patients infectés par le VIH au Maroc ]

Author(s): Hsai Fatima Ezzahra, Rachid El Faiz, Mahir Loubna, Asmaa Drissi Bourhanbour, Jalila El Bakkouri, Hanane Badi, Latifa Marih, Mustapha Sodqi, and Kamal Marhoum Elfilali
Show abstract   Full Text
2023 39 (3) , pp. 1347-1353
Seroprevalence of antinuclear antibodies in patients previously exposed to hepatitis B virus
[ Séroprévalence des anticorps antinucléaires chez les patients préalablement exposés au VHB ]

Author(s): Fassih Mohamed, Moryno Hiba, Drissi Bourhanbour Asma, and Jalila El Bakkouri
Show abstract   Full Text
2022 36 (2) , pp. 329-334
Evaluation of the ELISA technique compared to Immunodot in the screening of extractable nuclear antigens antibodies Sm, SSA and SSB
Author(s): Boutayna Khadiry, Meriem El Kerch, Brahim Farouki, Brahim Takourt, Jalila El Bakkouri, and Hassan Fellah
Show abstract   Full Text
2022 36 (2) , pp. 493-501


تقديم

مستجدات

إرسال المقالات

للتحميل

الأرشيف

البحث في الموقع

للاتصال

  • إتصل بنا
  • الرسالة الدورية:

تابعنا